Readystate Asset Management »

Cytokinetics shares owned by Readystate Asset Management

Quarter-by-quarter ownership of Cytokinetics shares owned by Readystate Asset Management from 13F filings

Historical chart of Readystate Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Readystate Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Readystate Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $24M 18M 1.29
2023-12-31 $27M 15M 1.76
2023-09-30 $28M 32M 0.85

More positions owned by Readystate Asset Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Granite Constr Note 3.750% 5/1 (Principal)
Transmedics Group Note 1.500% 6/0 (Principal)
Hess (HES)
Freshpet Note 3.000% 4/0 (Principal)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Workiva Note 1.250% 8/1 (Principal)
Amphastar Pharmaceuticals In Note 2.000% 3/1 (Principal)
Impinj Note 1.125% 5/1 (Principal)
Walt Disney Company (DIS)
Alphabet Cap Stk Cl C (GOOG)
Dayforce Note 0.250% 3/1 (Principal)
NVIDIA Corporation Call Option (NVDA)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)

View all positions for Readystate Asset Management

Top funds holding Cytokinetics

Linden Advisors
Wolverine Asset Management
Point72 Asset Management
Lazard Asset Management
FMR
Readystate Asset Management
CNH Partners
Aequim Alternative Investments
State Street Corporation
Oaktree Capital Management
DeepCurrents Investment Group
Aristeia Capital
Polygon Management
Two Sigma Investments
BlackRock

View all funds holding Cytokinetics